Skip to main content

ORIGINAL RESEARCH article

Front. Pharmacol.
Sec. Ethnopharmacology
Volume 15 - 2024 | doi: 10.3389/fphar.2024.1404693

Phillyrin ameliorates DSS-induced colitis in mice via modulating the gut microbiota and inhibiting the NF-κB/MLCK pathway

Provisionally accepted
Tong Li Tong Li *shoupeng fu shoupeng fu *Di Qin Di Qin *yuan ju yuan ju *Zheyu Song Zheyu Song *qiu Hui qiu Hui *
  • Jilin University, Changchun, China

The final, formatted version of the article will be published soon.

    Phillyrin (PHY), also known as forsythin, is one of the active constituents isolated from the fruits of Forsythia suspensa (Thunb.) Vahl (Oleaceae). It exhibits antiinflammatory, antiviral, and antioxidant properties. However, the precise impact of PHY on colitis induced by dextran sodium sulfate (DSS) and its mechanism remains elusive. The present investigation revealed that PHY (12.5, 25, and 50 mg/kg) exhibited significant therapeutic efficacy in protecting mice against DSS-induced colitis. This effect was manifested as reduced weight loss, shortened colon, increased secretion of inflammatory factors, increased intestinal permeability, and enhanced disease activity index (DAI) in Ulcerative Colitis (UC) mice. Molecular investigations have elucidated that PHY mitigates the nuclear translocation of nuclear factor kappa B (NF-κB), thereby downregulating Myosin Light-chain kinase (MLCK)-driven MLC phosphorylation (p-MLC). This mechanism results in the preservation of the integrity of the intestinal barrier. The outcomes of 16S rRNA sequencing suggested that PHY (50 mg/kg) augmented the relative abundance of certain probiotic strains, including Lactobacillaceae and Lachnospiraceae. Additionally, PHY supplementation elevated the short-chain fatty acid contents within the intestinal contents of UC mice. In summary, pre-treatment with PHY may ameliorate the DSS-induced UC in mice by lowering the expression of inflammatory factors, protecting intestinal barrier function, and enhancing the structure of intestinal flora.

    Keywords: phillyrin, DSS, Gut Microbiota, uc, intestinal barrier

    Received: 21 Mar 2024; Accepted: 15 May 2024.

    Copyright: © 2024 Li, fu, Qin, ju, Song and Hui. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence:
    Tong Li, Jilin University, Changchun, China
    shoupeng fu, Jilin University, Changchun, China
    Di Qin, Jilin University, Changchun, China
    yuan ju, Jilin University, Changchun, China
    Zheyu Song, Jilin University, Changchun, China
    qiu Hui, Jilin University, Changchun, China

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.